Liat Sidi
Director/Board Member at SCISPARC LTD.
Net worth: - $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Amitay Weiss | M | 62 | 4 years | |
Oz Adler | M | 36 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 7 years |
Zeev Levenberg | M | 60 | 15 years | |
Haim Siboni | M | 63 | 47 years | |
Roy Borochov | M | 49 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
David Palach | M | 58 | 4 years | |
Moshe Revach | M | 85 | 4 years | |
Assi Rotbart | M | 49 | 5 years | |
Itschak Shrem | M | 76 | 4 years | |
Tomer Izraeli | M | 46 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 19 years |
Tal Yaron Eldar | F | 60 | 8 years | |
Amnon Ben Shay | M | 61 | 3 years | |
Rinat Gazit | M | 60 | 5 years | |
Israel Berenshtein | M | 53 | 4 years | |
Lior Vider | M | 47 | 4 years | |
Dadi Segal | M | 48 | 5 years | |
Daniel Avidan | M | 62 | 7 years | |
Alon Dayan | M | 47 | 3 years | |
Udi Kalifi | M | 45 | 3 years | |
Aharoni Ehud | M | 65 | 8 years | |
Ronen Rosenbloom | M | 52 | 4 years | |
Eliyhow Arbiv | M | 57 | 3 years | |
Vered Raz Avayo | F | 54 | 7 years | |
Rinat Gazit | F | 54 | 5 years | |
Eliyahu Yoresh | M | 54 | 14 years | |
Liron Carmel | M | 39 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 years |
Nir Ben Yosef | M | 48 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Asaf Itzhaik | M | - | 1 years | |
Yaki Baranes | M | 42 | 1 years | |
Raul Srugo | M | 60 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Daphna Avital | F | 57 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 3 years |
Tidhar Turgeman | M | 44 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 years |
Lital Barda | F | 37 | 1 years | |
Asaf Itzhaik | M | 51 | 1 years | |
Moshe Scherf | M | 40 | 3 years | |
Alain Charlois | M | - | 4 years | |
Levy Zruya | M | 74 | 5 years | |
Adi Zuloff-Shani | M | 53 | 8 years | |
Sivan Scherf | F | 37 | 9 years | |
Eran Goldberg | M | 49 | 5 years | |
Ido Cnaan | M | 57 | 15 years | |
Oren Bar-On | M | 52 | 7 years | |
Joseph Ginossar | M | 65 | 6 years | |
Suzette Ramcharan | F | 45 | 1 years | |
Doron Cohadier | M | 50 | 7 years | |
Eyal S. Ron | M | 69 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | 4 years |
Yehonatan Zalman Vinokur | M | 46 |
Polyrizon Ltd.
Polyrizon Ltd. BiotechnologyHealth Technology Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ariel Dor | M | 43 | - | |
Michael Gally | M | 64 | 5 years | |
Ascher Shmulewitz | M | 67 | 7 years | |
Gilad Bar-Lev | M | - | - | |
Zohar Heiblum | M | 69 | 7 years | |
Yafit Stark | M | 71 | 5 years | |
Todd Violette | M | - | - | |
Amit Berger | M | 59 | 6 years | |
Eran Meytal | M | 53 | 2 years | |
Shaul Gilad | M | 59 | - | |
Roee Tamary | M | 43 | 3 years | |
Hana Mazal Margaliot | F | 54 | 3 years | |
Stephen Simes | M | 72 | 4 years | |
Arie Webber | M | - | - | |
Lior Amit | M | 58 | - | |
Orit Freedman Weissman | F | 60 | 3 years | |
Dror Elbaz | M | 44 | - | |
Ari Shamiss | M | 65 | - | |
Ran Moshe Shachak | M | 53 | 2 years | |
Shoshana Zaiag | F | 54 | 6 years | |
Jonathan Kolber | M | 62 | 3 years | |
Michal Marom Brikman | F | 54 | 3 years | |
Arie Shaked | M | 74 | 3 years | |
Samuel Ravina | M | 65 | 3 years | |
Gil Benyamini | M | 50 | - | |
David Lempert | M | 37 | - | |
Nisso Moyal | M | 45 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 72 | 97.30% |
Canada | 2 | 2.70% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Liat Sidi
- Personal Network